A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...

The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...

Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

A new blood test may help detect pancreatic cancer in its early stages with up to 97% accuracy, according to a recent study.